These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 8496751)

  • 1. T cell activation and cytokine release in streptococcal toxic shock-like syndrome.
    Nadal D; Lauener RP; Braegger CP; Kaufhold A; Simma B; Lütticken R; Seger RA
    J Pediatr; 1993 May; 122(5 Pt 1):727-9. PubMed ID: 8496751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Superantigens and toxic shock syndrome. A report of three cases treated with intravenous gammaglobulin].
    Vázquez García RE; Hernández Bautista V; Espinosa Padilla S
    Rev Alerg Mex; 2006; 53(5):183-8. PubMed ID: 17357565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Superantigenic activity produced by group A streptococcal isolates is neutralized by plasma from IVIG-treated streptococcal toxic shock syndrome patients.
    Norrby-Teglund A; Low DE; McGeer A; Kotb M
    Adv Exp Med Biol; 1997; 418():563-6. PubMed ID: 9331714
    [No Abstract]   [Full Text] [Related]  

  • 4. Adjunctive treatment of streptococcal toxic shock syndrome using intravenous immunoglobulin: case report and review.
    Perez CM; Kubak BM; Cryer HG; Salehmugodam S; Vespa P; Farmer D
    Am J Med; 1997 Jan; 102(1):111-3. PubMed ID: 9209207
    [No Abstract]   [Full Text] [Related]  

  • 5. Streptococcal toxic shock-like syndrome as a complication of varicella.
    Bradley JS; Schlievert PM; Sample TG
    Pediatr Infect Dis J; 1991 Jan; 10(1):77-9. PubMed ID: 2003062
    [No Abstract]   [Full Text] [Related]  

  • 6. Rationale for the use of intravenous gamma globulin in the treatment of streptococcal toxic shock syndrome.
    Stevens DL
    Clin Infect Dis; 1998 Mar; 26(3):639-41. PubMed ID: 9524836
    [No Abstract]   [Full Text] [Related]  

  • 7. Case report: streptococcal toxic shock syndrome presenting as septic thrombophlebitis in a child with varicella.
    Cohen-Abbo A; Harper MB
    Pediatr Infect Dis J; 1993 Dec; 12(12):1033-4. PubMed ID: 8108215
    [No Abstract]   [Full Text] [Related]  

  • 8. Superantigens and streptococcal toxic shock syndrome.
    Proft T; Sriskandan S; Yang L; Fraser JD
    Emerg Infect Dis; 2003 Oct; 9(10):1211-8. PubMed ID: 14609454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dilemmas in the treatment of invasive Streptococcus pyogenes infections.
    Stevens DL
    Clin Infect Dis; 2003 Aug; 37(3):341-3. PubMed ID: 12884157
    [No Abstract]   [Full Text] [Related]  

  • 10. Plasma from patients with severe invasive group A streptococcal infections treated with normal polyspecific IgG inhibits streptococcal superantigen-induced T cell proliferation and cytokine production.
    Norrby-Teglund A; Kaul R; Low DE; McGeer A; Newton DW; Andersson J; Andersson U; Kotb M
    J Immunol; 1996 Apr; 156(8):3057-64. PubMed ID: 8609429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Congenital streptococcal toxic shock syndrome with absence of antibodies against streptococcal pyrogenic exotoxins.
    Mahieu LM; Holm SE; Goossens HJ; Van Acker KJ
    J Pediatr; 1995 Dec; 127(6):987-9. PubMed ID: 8523204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergic activities of streptococcal pyrogenic exotoxin A and lipoteichoic acid in cytokine induction.
    Cusumano V; Fera MT; Carbone M; Anzani Ciliberti F; Bellantoni A; Cusumano V
    New Microbiol; 2000 Jan; 23(1):37-45. PubMed ID: 10946404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Streptococcal toxic shock syndrome (STSS). An update: a roundtable presentation.
    Holm SE; Köhler W; Kaplan EL; Schlievert PM; Alouf JE; Stevens DL; Kotb M
    Adv Exp Med Biol; 1997; 418():193-9. PubMed ID: 9331631
    [No Abstract]   [Full Text] [Related]  

  • 14. Streptococcal toxic shock syndrome complicating varicella in children.
    Yang YJ; Liu CC; Wang SM; Huang CC; Wu JJ
    J Formos Med Assoc; 1997 Sep; 96(9):749-53. PubMed ID: 9308331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonged varicella viraemia and streptococcal toxic shock syndrome following varicella vaccination of a health care worker.
    Italiano CM; Toi CS; Chan SP; Dwyer DE
    Med J Aust; 2009 Apr; 190(8):451-3. PubMed ID: 19374621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical usefulness of intravenous human immunoglobulins in invasive group A Streptococcal infections: case report and review.
    Lamothe F; D'Amico P; Ghosn P; Tremblay C; Braidy J; Patenaude JV
    Clin Infect Dis; 1995 Dec; 21(6):1469-70. PubMed ID: 8749635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lethal shock induced by streptococcal pyrogenic exotoxin A in mice transgenic for human leukocyte antigen-DQ8 and human CD4 receptors: implications for development of vaccines and therapeutics.
    Welcher BC; Carra JH; DaSilva L; Hanson J; David CS; Aman MJ; Bavari S
    J Infect Dis; 2002 Aug; 186(4):501-10. PubMed ID: 12195377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Streptococcal toxic shock syndrome associated with marked gamma delta T cell expansion: case report.
    Arvand M; Schneider T; Jahn HU; Hahn H
    Clin Infect Dis; 1996 Feb; 22(2):362-5. PubMed ID: 8838197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in potency of intravenous polyspecific immunoglobulin G against streptococcal and staphylococcal superantigens: implications for therapy of toxic shock syndrome.
    Darenberg J; Söderquist B; Normark BH; Norrby-Teglund A
    Clin Infect Dis; 2004 Mar; 38(6):836-42. PubMed ID: 14999628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous immunoglobulin therapy for toxic shock syndrome.
    Barry W; Hudgins L; Donta ST; Pesanti EL
    JAMA; 1992 Jun; 267(24):3315-6. PubMed ID: 1597914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.